Click for best price
Rare Disease Clinical Trial Market Size, Share 2024
The global Rare Disease Clinical Trial market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Stage I Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Rare Disease Clinical Trial include Takeda Pharmaceutical Company, F. Hoffmann-La Roche, Pfizer, AstraZeneca, Novartis AG, LabCorp, IQVIA, Charles River Laboratories and Icon PLC, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Rare Disease Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Disease Clinical Trial. This report contains market size and forecasts of Rare Disease Clinical Trial in global, including the following market information:
- Global Rare Disease Clinical Trial Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global top five companies in 2023 (%)
We surveyed the Rare Disease Clinical Trial companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rare Disease Clinical Trial Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Rare Disease Clinical Trial Market Segment Percentages, by Type, 2023 (%)
Global Rare Disease Clinical Trial Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Rare Disease Clinical Trial Market Segment Percentages, by Application, 2023 (%)
- Autoimmunity and Inflammation
- Blood System Disease
- Other
Global Rare Disease Clinical Trial Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Rare Disease Clinical Trial Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rare Disease Clinical Trial revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Rare Disease Clinical Trial revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Takeda Pharmaceutical Company
- F. Hoffmann-La Roche
- Pfizer
- AstraZeneca
- Novartis AG
- LabCorp
- IQVIA
- Charles River Laboratories
- Icon PLC
- Parexel International Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Rare Disease Clinical Trial, market overview.
Chapter 2: Global Rare Disease Clinical Trial market size in revenue.
Chapter 3: Detailed analysis of Rare Disease Clinical Trial company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Rare Disease Clinical Trial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Rare Disease Clinical Trial Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Rare Disease Clinical Trial Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Rare Disease Clinical Trial Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Rare Disease Clinical Trial Overall Market Size
2.1 Global Rare Disease Clinical Trial Market Size: 2023 VS 2030
2.2 Global Rare Disease Clinical Trial Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Rare Disease Clinical Trial Players in Global Market
3.2 Top Global Rare Disease Clinical Trial Companies Ranked by Revenue
3.3 Global Rare Disease Clinical Trial Revenue by Companies
3.4 Top 3 and Top 5 Rare Disease Clinical Trial Companies in Global Market, by Revenue in 2023
3.5 Global Companies Rare Disease Clinical Trial Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rare Disease Clinical Trial Players in Global Market
3.6.1 List of Global Tier 1 Rare Disease Clinical Trial Companies
3.6.2 List of Global Tier 2 and Tier 3 Rare Disease Clinical Trial Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Rare Disease Clinical Trial Market Size Markets, 2023 & 2030
4.1.2 Stage I
4.1.3 Phase II
4.2 By Type - Global Rare Disease Clinical Trial Revenue & Forecasts
4.2.1 By Type - Global Rare Disease Clinical Trial Revenue, 2019-2024
4.2.2 By Type - Global Rare Disease Clinical Trial Revenue, 2025-2030
4.2.3 By Type - Global Rare Disease Clinical Trial Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Rare Disease Clinical Trial Market Size, 2023 & 2030
5.1.2 Autoimmunity and Inflammation
5.1.3 Blood System Disease
5.1.4 Other
5.2 By Application - Global Rare Disease Clinical Trial Revenue & Forecasts
5.2.1 By Application - Global Rare Disease Clinical Trial Revenue, 2019-2024
5.2.2 By Application - Global Rare Disease Clinical Trial Revenue, 2025-2030
5.2.3 By Application - Global Rare Disease Clinical Trial Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Rare Disease Clinical Trial Market Size, 2023 & 2030
6.2 By Region - Global Rare Disease Clinical Trial Revenue & Forecasts
6.2.1 By Region - Global Rare Disease Clinical Trial Revenue, 2019-2024
6.2.2 By Region - Global Rare Disease Clinical Trial Revenue, 2025-2030
6.2.3 By Region - Global Rare Disease Clinical Trial Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Rare Disease Clinical Trial Revenue, 2019-2030
6.3.2 US Rare Disease Clinical Trial Market Size, 2019-2030
6.3.3 Canada Rare Disease Clinical Trial Market Size, 2019-2030
6.3.4 Mexico Rare Disease Clinical Trial Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Rare Disease Clinical Trial Revenue, 2019-2030
6.4.2 Germany Rare Disease Clinical Trial Market Size, 2019-2030
6.4.3 France Rare Disease Clinical Trial Market Size, 2019-2030
6.4.4 U.K. Rare Disease Clinical Trial Market Size, 2019-2030
6.4.5 Italy Rare Disease Clinical Trial Market Size, 2019-2030
6.4.6 Russia Rare Disease Clinical Trial Market Size, 2019-2030
6.4.7 Nordic Countries Rare Disease Clinical Trial Market Size, 2019-2030
6.4.8 Benelux Rare Disease Clinical Trial Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Rare Disease Clinical Trial Revenue, 2019-2030
6.5.2 China Rare Disease Clinical Trial Market Size, 2019-2030
6.5.3 Japan Rare Disease Clinical Trial Market Size, 2019-2030
6.5.4 South Korea Rare Disease Clinical Trial Market Size, 2019-2030
6.5.5 Southeast Asia Rare Disease Clinical Trial Market Size, 2019-2030
6.5.6 India Rare Disease Clinical Trial Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Rare Disease Clinical Trial Revenue, 2019-2030
6.6.2 Brazil Rare Disease Clinical Trial Market Size, 2019-2030
6.6.3 Argentina Rare Disease Clinical Trial Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Rare Disease Clinical Trial Revenue, 2019-2030
6.7.2 Turkey Rare Disease Clinical Trial Market Size, 2019-2030
6.7.3 Israel Rare Disease Clinical Trial Market Size, 2019-2030
6.7.4 Saudi Arabia Rare Disease Clinical Trial Market Size, 2019-2030
6.7.5 UAE Rare Disease Clinical Trial Market Size, 2019-2030
7 Rare Disease Clinical Trial Companies Profiles
7.1 Takeda Pharmaceutical Company
7.1.1 Takeda Pharmaceutical Company Company Summary
7.1.2 Takeda Pharmaceutical Company Business Overview
7.1.3 Takeda Pharmaceutical Company Rare Disease Clinical Trial Major Product Offerings
7.1.4 Takeda Pharmaceutical Company Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.1.5 Takeda Pharmaceutical Company Key News & Latest Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Rare Disease Clinical Trial Major Product Offerings
7.2.4 F. Hoffmann-La Roche Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.2.5 F. Hoffmann-La Roche Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Rare Disease Clinical Trial Major Product Offerings
7.3.4 Pfizer Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.3.5 Pfizer Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Rare Disease Clinical Trial Major Product Offerings
7.4.4 AstraZeneca Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Novartis AG
7.5.1 Novartis AG Company Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Rare Disease Clinical Trial Major Product Offerings
7.5.4 Novartis AG Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.5.5 Novartis AG Key News & Latest Developments
7.6 LabCorp
7.6.1 LabCorp Company Summary
7.6.2 LabCorp Business Overview
7.6.3 LabCorp Rare Disease Clinical Trial Major Product Offerings
7.6.4 LabCorp Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.6.5 LabCorp Key News & Latest Developments
7.7 IQVIA
7.7.1 IQVIA Company Summary
7.7.2 IQVIA Business Overview
7.7.3 IQVIA Rare Disease Clinical Trial Major Product Offerings
7.7.4 IQVIA Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.7.5 IQVIA Key News & Latest Developments
7.8 Charles River Laboratories
7.8.1 Charles River Laboratories Company Summary
7.8.2 Charles River Laboratories Business Overview
7.8.3 Charles River Laboratories Rare Disease Clinical Trial Major Product Offerings
7.8.4 Charles River Laboratories Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.8.5 Charles River Laboratories Key News & Latest Developments
7.9 Icon PLC
7.9.1 Icon PLC Company Summary
7.9.2 Icon PLC Business Overview
7.9.3 Icon PLC Rare Disease Clinical Trial Major Product Offerings
7.9.4 Icon PLC Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.9.5 Icon PLC Key News & Latest Developments
7.10 Parexel International Corporation
7.10.1 Parexel International Corporation Company Summary
7.10.2 Parexel International Corporation Business Overview
7.10.3 Parexel International Corporation Rare Disease Clinical Trial Major Product Offerings
7.10.4 Parexel International Corporation Rare Disease Clinical Trial Revenue in Global Market (2019-2024)
7.10.5 Parexel International Corporation Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Rare Disease Clinical Trial Market Opportunities & Trends in Global Market
Table 2. Rare Disease Clinical Trial Market Drivers in Global Market
Table 3. Rare Disease Clinical Trial Market Restraints in Global Market
Table 4. Key Players of Rare Disease Clinical Trial in Global Market
Table 5. Top Rare Disease Clinical Trial Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Rare Disease Clinical Trial Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Rare Disease Clinical Trial Revenue Share by Companies, 2019-2024
Table 8. Global Companies Rare Disease Clinical Trial Product Type
Table 9. List of Global Tier 1 Rare Disease Clinical Trial Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rare Disease Clinical Trial Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Rare Disease Clinical Trial Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Rare Disease Clinical Trial Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Rare Disease Clinical Trial Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Rare Disease Clinical Trial Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Rare Disease Clinical Trial Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Rare Disease Clinical Trial Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Rare Disease Clinical Trial Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Rare Disease Clinical Trial Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Rare Disease Clinical Trial Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Rare Disease Clinical Trial Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Rare Disease Clinical Trial Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Rare Disease Clinical Trial Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Rare Disease Clinical Trial Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Rare Disease Clinical Trial Revenue, (US$, Mn), 2025-2030
Table 30. Takeda Pharmaceutical Company Company Summary
Table 31. Takeda Pharmaceutical Company Rare Disease Clinical Trial Product Offerings
Table 32. Takeda Pharmaceutical Company Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 33. Takeda Pharmaceutical Company Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Company Summary
Table 35. F. Hoffmann-La Roche Rare Disease Clinical Trial Product Offerings
Table 36. F. Hoffmann-La Roche Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 37. F. Hoffmann-La Roche Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Rare Disease Clinical Trial Product Offerings
Table 40. Pfizer Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 41. Pfizer Key News & Latest Developments
Table 42. AstraZeneca Company Summary
Table 43. AstraZeneca Rare Disease Clinical Trial Product Offerings
Table 44. AstraZeneca Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 45. AstraZeneca Key News & Latest Developments
Table 46. Novartis AG Company Summary
Table 47. Novartis AG Rare Disease Clinical Trial Product Offerings
Table 48. Novartis AG Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 49. Novartis AG Key News & Latest Developments
Table 50. LabCorp Company Summary
Table 51. LabCorp Rare Disease Clinical Trial Product Offerings
Table 52. LabCorp Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 53. LabCorp Key News & Latest Developments
Table 54. IQVIA Company Summary
Table 55. IQVIA Rare Disease Clinical Trial Product Offerings
Table 56. IQVIA Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 57. IQVIA Key News & Latest Developments
Table 58. Charles River Laboratories Company Summary
Table 59. Charles River Laboratories Rare Disease Clinical Trial Product Offerings
Table 60. Charles River Laboratories Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 61. Charles River Laboratories Key News & Latest Developments
Table 62. Icon PLC Company Summary
Table 63. Icon PLC Rare Disease Clinical Trial Product Offerings
Table 64. Icon PLC Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 65. Icon PLC Key News & Latest Developments
Table 66. Parexel International Corporation Company Summary
Table 67. Parexel International Corporation Rare Disease Clinical Trial Product Offerings
Table 68. Parexel International Corporation Rare Disease Clinical Trial Revenue (US$, Mn) & (2019-2024)
Table 69. Parexel International Corporation Key News & Latest Developments
List of Figures
Figure 1. Rare Disease Clinical Trial Segment by Type in 2023
Figure 2. Rare Disease Clinical Trial Segment by Application in 2023
Figure 3. Global Rare Disease Clinical Trial Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Rare Disease Clinical Trial Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Rare Disease Clinical Trial Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rare Disease Clinical Trial Revenue in 2023
Figure 8. By Type - Global Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 9. By Application - Global Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 10. By Type - Global Rare Disease Clinical Trial Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 12. By Application - Global Rare Disease Clinical Trial Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 14. By Region - Global Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 15. By Country - North America Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 16. US Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 20. Germany Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 21. France Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 28. China Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 32. India Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 34. Brazil Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Rare Disease Clinical Trial Revenue Market Share, 2019-2030
Figure 37. Turkey Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Rare Disease Clinical Trial Revenue, (US$, Mn), 2019-2030
Figure 41. Takeda Pharmaceutical Company Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. F. Hoffmann-La Roche Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Pfizer Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. AstraZeneca Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Novartis AG Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. LabCorp Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. IQVIA Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Charles River Laboratories Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Icon PLC Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Parexel International Corporation Rare Disease Clinical Trial Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
